People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Achieve Life Sciences, Inc. | — | Biotechnology | Series B | $28.9M | $270.0M | 2009 |
Neil James Clendeninn at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Neil James Clendeninn on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Bencich | 1 | 3 |
| Anthony Clarke | 1 | 2 |
| Michael A. Martino | 1 | 2 |
| Jay Moyes | 1 | 2 |
| Cindy Jacobs | 1 | 2 |
| Donald Joseph | 1 | 2 |
| Bridget Martell | 1 | 1 |
| Martin Mattingly | 1 | 1 |
| Jaime Xinos | 1 | 1 |
| Vaughn Himes | 1 | 1 |
| Richard Stewart | 1 | 1 |
| Cindy A. Jacobs | 1 | 1 |
| Stephen A. Anderson | 1 | 1 |
| Scott Cormack | 1 | 1 |
| Michelle A. Burris | 1 | 1 |
| Dwight A. Winstead | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.